Skip to main content
. Author manuscript; available in PMC: 2007 Jun 29.
Published in final edited form as: Life Sci. 2006 Aug 2;79(24):2311–2319. doi: 10.1016/j.lfs.2006.07.031

Table 1.

Structure and potency of sEHIs used in this study

Inhibitor Structure Human IC50
AUDA-be graphic file with name nihms21277t1.jpg 0.8 nM
IK 950 graphic file with name nihms21277t2.jpg 4.3 nM

Both inhibitors contain a urea primary pharmacophore. Although IK-950 is more water soluble compared to AUDA-be both inhibitors were effective topically when formulated into a cream. The IC50 refers to the potency of inhibition of the indicated compound on the recombinant human enzyme in vitro.